Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03896061 · ClinicalTrials.gov registry record
A Videographic Study to Evaluate the Impact of a Pulsed Firing Technique on Staple Line Interventions in Laparoscopic Sleeve Gastrectomy
A clinical trial, sponsored by Ethicon.
- Completed
- Registry status
- 62
- Enrollment target
NCT03896061: Completed study, sponsored by Ethicon.
NCT03896061 is a clinical trial that has completed, run by Ethicon. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03896061 has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
Prospective, multi-center study will evaluate a pulsing technique with the ECHELON FLEX GST system for hemostasis at the staple line in laparoscopic sleeve gastrectomy procedures.
Primary Outcome
Investigate whether use of a prescribed pulsing technique may provide potential reduction in the occurrence of oozing/bleeding at the staple line.
Interventions
- DEVICE Laparoscopic sleeve procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2019-12-31 |
What the finished NCT03896061 record still lists
NCT03896061 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Laparoscopic sleeve procedures is the first listed.
NCT03896061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03896061 about?
NCT03896061 is a clinical study titled "A Videographic Study to Evaluate the Impact of a Pulsed Firing Technique on Staple Line Interventions in Laparoscopic Sleeve Gastrectomy". Prospective, multi-center study will evaluate a pulsing technique with the ECHELON FLEX GST system for hemostasis at the staple line in laparoscopic sleeve gastrectomy procedures.
What is the current status of trial NCT03896061?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2019-04-15. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03896061?
The interventions under investigation include: Laparoscopic sleeve procedures (DEVICE).
Who is sponsoring clinical trial NCT03896061?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI